Clinical Trial Update: A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial conducted by Astellas in men with diarrhea-predominant irritable bowel syndrome to explore clinical endpoints; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Irritable Bowel Syndrome | Phase 4 | Status: COMPLETED